Physician profile
Eric S Holender
NPI 1992768543
$2,215.97
in general payments reported to CMS, 2019-2025
18 companies · $825 in 2025
The $825 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.12 · 2020: $120 · 2021: $43.28 · 2022: $242 · 2023: $401 · 2024: $523 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $448.62 | 2022-2025 | Nucala |
| Genzyme Corporation | $415.34 | 2019-2025 | |
| Inspire Medical Systems, INC. | $291.78 | 2023-2025 | Inspire |
| Neurent Medical Limited | $216.45 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Aerin Medical INC. | $203.20 | 2019-2025 | |
| Optinose US, INC. | $191.35 | 2020-2025 | |
| Medtronic, INC. | $115.10 | 2025 | Nim Vital, Propel |
| Stryker Corporation | $69.99 | 2019-2023 | Audion Et Dilation System |
| Organogenesis INC. | $49.61 | 2025 | Affinity |
| Regeneron Healthcare Solutions, INC. | $47.60 | 2024-2025 | Dupixent |
| Axogen | $28.68 | 2020 | |
| Intersect Ent, INC. | $27.49 | 2020 | |
| Hikma Pharmaceuticals USA | $23.82 | 2023 | Ryaltris |
| Merck Sharp & Dohme LLC | $18.67 | 2023 | |
| Amgen INC. | $18.19 | 2025 | Tezspire |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $17.58 | 2025 | Xhance |
| Pfizer INC. | $17.54 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $14.96 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Holender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.